相关因子 转诊 低视力 对于 患有晚期玻璃眼的患者
Julia Ernst1,2, Janice Huang2,3, Jakob Tsosie1
1Department of Ophthalmology, Tufts University School of Medicine-Lahey School of Medicine, 31 Burlington Mall Rd, Burlington, MA 01805, USA.
Life (Basel, Switzerland)
|January 28, 2026
概括
大多数符合低视力康复 (LVR) 资格的严重开角青光眼 (OAG) 患者不会被转诊. 视力敏度,而不是视野损失,显著影响OAG患者的LVR转诊率.
科学领域:
- 眼科医生 眼科 眼科
- 低视力康复治疗 低视力康复治疗
- 视光眼管理 视光眼管理
背景情况:
- 玻璃眼是全球不可逆转的视力丧失的主要原因.
- 低视力康复 (LVR) 服务对于永久视力损伤的患者至关重要.
- 严重的开角玻璃眼 (OAG) 患者面临着渐进的视力障碍.
研究的目的:
- 评估严重OAG患者的转诊率,以获得LVR服务.
- 在这个人群中确定与LVR转诊相关的因素.
- 评估符合条件的OAG患者的LVR的结果.
主要方法:
- 在一个学术医疗中心对522名严重OAG患者进行了回顾性,横截面研究.
- 抽象的数据包括人口统计,青光眼的严重程度,视敏度 (VA),视野 (VF) 测试和最佳校正视敏度 (BCVA).
- 后勤回归分析了影响LVR转诊的因素,重点关注VA和VF损失.
主要成果:
- 只有2.7% (14/522) 的符合条件的严重OAG患者被转诊为LVR.
- 转诊与呈现视敏度 (aOR=7.20,p=0.001) 有着强烈的关联,但没有视敏度损失 (aOR=0.90,p=0.876).
- 在被转诊的患者中,93%完成了视察,超过三分之一的患者在低视力折射后视力得到改善.
结论:
- 大多数符合LVR标准的严重OAG患者没有被转诊.
- 转诊实践可能无法充分考虑LVR在治疗视力障碍方面的好处.
- 视力敏度是OAG患者LVR转诊决定的一个关键因素.
相关概念视频
Factors Affecting Protein-Drug Binding: Patient-Related Factors
322
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
322
Vision
60.0K
Vision is the result of light being detected and transduced into neural signals by the retina of the eye. This information is then further analyzed and interpreted by the brain. First, light enters the front of the eye and is focused by the cornea and lens onto the retina—a thin sheet of neural tissue lining the back of the eye. Because of refraction through the convex lens of the eye, images are projected onto the retina upside-down and reversed.
60.0K
Glaucoma: Overview
1.4K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.4K
Color Vision
1.5K
Color perception begins in the retina, the light-sensitive layer at the back of the eye. Two main theories explain how colors are seen: the trichromatic theory and the opponent-process theory. The trichromatic theory, proposed by Thomas Young in 1802 and extended by Hermann von Helmholtz in 1852, suggests that color vision is based on three types of cone receptors in the retina. These cones are sensitive to different but overlapping ranges of wavelengths corresponding to red, blue, and green.
1.5K
Open Angle Glaucoma: Treatment
990
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
990
Angle Closure Glaucoma: Treatment
1.2K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.2K


